SPARC is expressed in renal interstitial fibrosis and in renal vascular injury

This publication has 35 references indexed in Scilit:

• Renal fibroblasts are sensitive to growth-repressing and matrix-reducing factors from activated lymphocytes
  Clinical and Experimental Immunology, 2008
• SPARC gene expression is reduced in early diabetes-related kidney growth
  Kidney International, 1995
• Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca²⁺‐binding EF‐hand sequence
  Journal of Cellular Biochemistry, 1995
• Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization.
  Journal of Histochemistry & Cytochemistry, 1993
• Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro
  Biochemistry and Cell Biology, 1992
• Renal injury from angiotensin II-mediated hypertension.
  Hypertension, 1992
• Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.
  Hypertension, 1991
• A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.
  The Journal of cell biology, 1986
• The biology of platelet-derived growth factor
  Cell, 1986
• Influence of the Renal Cortical Interstitium on the Serum Creatinine Concentration and Serum Creatinine Clearance in Different Chronic Sclerosing Interstitial Nephritides
  Nephron, 1979